tiprankstipranks
Maxim Group Sticks to Their Buy Rating for urban-gro (UGRO)
Blurbs

Maxim Group Sticks to Their Buy Rating for urban-gro (UGRO)

In a report released yesterday, Anthony Vendetti from Maxim Group maintained a Buy rating on urban-gro (UGROResearch Report). The company’s shares opened today at $1.21.

Vendetti covers the Healthcare sector, focusing on stocks such as Icecure Medical, Biolase, and Aethlon Medical. According to TipRanks, Vendetti has an average return of -3.2% and a 32.06% success rate on recommended stocks.

urban-gro has an analyst consensus of Moderate Buy, with a price target consensus of $600.00, a 49,486.78% upside from current levels. In a report released yesterday, Craig-Hallum also maintained a Buy rating on the stock with a $600.00 price target.

See the top stocks recommended by analysts >>

Based on urban-gro’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $18.84 million and a GAAP net loss of $5.44 million. In comparison, last year the company earned a revenue of $16.28 million and had a GAAP net loss of $1.74 million

Based on the recent corporate insider activity of 17 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of UGRO in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Urban-gro Inc is an agricultural solutions and ag-tech company focused on serving commercial cultivators around the world. It offers various equipment and products such as Pesticides & Equipment, Climate Control equipment, Fertigation products, Wastewater Treatment equipment and others.

Read More on UGRO:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles